Follow
Nicholas Cross
Nicholas Cross
Nephrologist, Canterbury District Health Board
Verified email at cdhb.govt.nz
Title
Cited by
Cited by
Year
Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities
G Wong, K Howard, JR Chapman, S Chadban, N Cross, A Tong, ...
PloS one 7 (1), e29591, 2012
2302012
A novel hypoxia-inducible factor− prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2A randomized trial
RA Brigandi, B Johnson, C Oei, M Westerman, G Olbina, J De Zoysa, ...
American Journal of Kidney Diseases 67 (6), 861-871, 2016
1692016
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients
P Hill, NB Cross, ANR Barnett, SC Palmer, AC Webster
Cochrane Database of Systematic Reviews, 2017
1382017
Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials
NB Cross, AC Webster, P Masson, PJ O'connell, JC Craig
Transplantation 88 (1), 7-18, 2009
1342009
Global transplantation COVID report March 2020
C Ahn, H Amer, D Anglicheau, NL Ascher, CC Baan, G Battsetset, ...
Transplantation 104 (10), 1974-1983, 2020
1092020
Treatment for peritoneal dialysis‐associated peritonitis
AE Ballinger, SC Palmer, KJ Wiggins, JC Craig, DW Johnson, NB Cross, ...
Cochrane Database of Systematic Reviews, 2014
1052014
Antihypertensive treatment for kidney transplant recipients
NB Cross, AC Webster, P Masson, PJ O'Connell, JC Craig
Cochrane Database of Systematic Reviews, 2009
922009
Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission
SL White, W Rawlinson, P Boan, V Sheppeard, G Wong, K Waller, ...
Transplantation direct 5 (1), e416, 2019
782019
Developing consensus-based priority outcome domains for trials in kidney transplantation: a multinational Delphi survey with patients, caregivers, and health professionals
B Sautenet, A Tong, KE Manera, JR Chapman, AN Warrens, ...
Transplantation 101 (8), 1875-1886, 2017
752017
Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells
BD Hock, KA Mackenzie, NB Cross, KG Taylor, MJ Currie, BA Robinson, ...
Nephrology Dialysis Transplantation 27 (1), 402-410, 2012
662012
The experiences of commercial kidney donors: thematic synthesis of qualitative research
A Tong, JR Chapman, G Wong, NB Cross, P Batabyal, JC Craig
Transplant International 25 (11), 1138-1149, 2012
562012
Health-related quality of life in people across the spectrum of CKD
A Krishnan, A Teixeira-Pinto, WH Lim, K Howard, JR Chapman, ...
Kidney international reports 5 (12), 2264-2274, 2020
462020
“It was just an unconditional gift.” Self reflections of non‐directed living kidney donors
A Tong, JC Craig, G Wong, J Morton, S Armstrong, J Schollum, N Cross
Clinical transplantation 26 (4), 589-599, 2012
442012
Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: a prospective study
BD Hock, JL McKenzie, NB Cross, MJ Currie
Transplant Immunology 32 (3), 164-171, 2015
302015
Beliefs and attitudes to bowel cancer screening in patients with CKD: a semistructured interview study
LJ James, G Wong, JC Craig, A Ju, N Williams, WH Lim, N Cross, A Tong
Clinical Journal of the American Society of Nephrology 12 (4), 568-576, 2017
262017
Asking the right question and finding the right answers
NB Cross, JC Craig, AC Webster
Nephrology 15 (1), 8-11, 2010
252010
One-time fecal immunochemical screening for advanced colorectal neoplasia in patients with CKD (DETECT study)
G Wong, RL Hope, K Howard, JR Chapman, A Castells, SD Roger, ...
Journal of the American Society of Nephrology 30 (6), 1061-1072, 2019
222019
A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis
DFB Wright, MP Doogue, ML Barclay, PT Chapman, NB Cross, JH Irvine, ...
European journal of clinical pharmacology 73, 71-78, 2017
202017
How to get the most from the medical literature: searching the medical literature effectively
AC Webster, NB Cross, R Mitchell, JC Craig
Nephrology 15 (1), 12-19, 2010
142010
PHI112844 Investigators: A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2A randomized trial
RA Brigandi, B Johnson, C Oei, M Westerman, G Olbina, J De Zoysa, ...
Am J Kidney Dis 67 (6), 861-871, 2016
122016
The system can't perform the operation now. Try again later.
Articles 1–20